MS
Meeta ShettyFund Manager Since 9 Mar 2021
EquitySector - Healthcare
Tata India Pharma & Healthcare Fund Direct Growth
3Y Annualised
25.22%
-1.76% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
-1.23%
-1.76% 1D
Benchmark
SBI Nifty 10 yr Benchmark G-Sec ETF
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
3 years 1 months
NIFTY 50
6 years 4 months
FD
9 years 7 months
Fund info
Fund size
₹1300.81 Cr
Min. SIP amount
₹100
Min. Lumpsum amount
₹5000
Exit load
0.0025%
0.25% of NAV if redeemed on or before expiry of 30 days from the date of allotment.
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Nippon India Nifty Pharma ETF
2.92%
2nd
Mirae Asset Healthcare Fund Direct Growth
2.53%
3rd
Mirae Asset Healthcare Fund Direct Reinvestment of Income Distribution cum capital withdrawal
2.53%
4th
Mirae Asset Healthcare Fund Direct Payout of Income Distribution cum capital withdrawal
2.53%
5th
Mirae Asset Healthcare Fund Regular Growth
2.41%
93rd
Tata India Pharma & Healthcare Fund Direct Growth
-1.23%
Fund Managers
About Tata India Pharma & Healthcare Fund Direct Growth
Tata India Pharma & Healthcare Fund Direct Growth is a Equity mutual fund scheme from Tata Asset Management Pvt Ltd. This fund has been in existence for 10 years, having been launched on 2015-12-28. Tata India Pharma & Healthcare Fund Direct Growth has ₹1300.81 Cr worth of assets under management (AUM) as of Tue Mar 17 2026. The latest Net Asset Value (NAV) of Tata India Pharma & Healthcare Fund Direct Growth as of Mon Mar 16 2026 is ₹33.8397. The fund has an expense ratio of 0.69%, which is medium comparable to most other Equity funds.
Tata India Pharma & Healthcare Fund Direct Growth returns for the last 1 year are 7.89%. Since launch, it has delivered 12.78% average annual returns.
The Tata India Pharma & Healthcare Fund Direct Growth has the majority of its money invested in Healthcare, Basic Materials sectors.
Top 5 Holdings of Tata India Pharma & Healthcare Fund Direct Growth.
- Sun Pharmaceuticals Industries Ltd: 9.66%
- Max Healthcare Institute Ltd Ordinary Shares: 6.78%
- Divi's Laboratories Ltd: 5.94%
- Abbott India Ltd: 5.60%
- HealthCare Global Enterprises Ltd: 5.04%
AMC Information
| Name | Tata Asset Management Pvt Ltd |
|---|---|
| Founding Date | 2015-12-28 |
| kiran@tataamc.com | |
| Phone | +91 22 6657 8282 |
| Website | www.tatamutualfund.com |
| Address | Tata Asset Management Private Limited,Mafatlal Centre, 9th Floor,,Nariman Point,,India |
Tax Implications of Tata India Pharma & Healthcare Fund Direct Growth
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from Tata Asset Management Pvt Ltd
Tata Large & Mid Cap Fund Regular Growth
EquityLarge & Mid-Cap
3Y CAGR
10.03%
expense ratio
1.78%
fund size
₹8143.28 Cr
Tata Short Term Bond Fund Regular Growth
Fixed IncomeShort Duration
3Y CAGR
6.69%
expense ratio
1.17%
fund size
₹3745.31 Cr
Tata Equity Savings Regular Growth
AllocationEquity Savings
3Y CAGR
9.85%
expense ratio
1.14%
fund size
₹284.62 Cr
Tata Mid Cap Fund Regular Growth
EquityMid-Cap
3Y CAGR
19.80%
expense ratio
1.83%
fund size
₹5505.28 Cr
Tata Value Fund Regular Growth
EquityValue
3Y CAGR
17.69%
expense ratio
1.79%
fund size
₹8774.06 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
